NP Application for Authority/Exemption to Prescribe Methadone for Opioid Dependence Part A (Initial application)

Size: px
Start display at page:

Download "NP Application for Authority/Exemption to Prescribe Methadone for Opioid Dependence Part A (Initial application)"

Transcription

1 NP Application for Authority/Exemption to Prescribe Methadone for Opioid Dependence Part A (Initial application) To prescribe Methadone, NPs are subject to Federal Government s Narcotic Control Regulations subsection 53(3) which requires practitioners to obtain a section 56 exemption under the Controlled Drugs and Substances Act (CDSA). Section 56 of the CDSA allows the Federal Minister of Health to issue exemptions if, in the opinion of this Minister, the exemptions are necessary for a medical or scientific purpose or is otherwise in the public interest. Health Canada will issue exemptions to NPs to prescribe Methadone upon recommendations from the Association of Registered Nurses of Newfoundland and Labrador. Complete each section and initial the bottom of each page. Section A: Name ARNNL NP Licensure/Registration # Phone Number Primary Address Address Manager Name Phone Number Employer(s) Address (include site/unit) Prescribing indication: Opioid Dependence Exemption length: 3 years Provide a description of your practice setting and applicability for this request to prescribe Methadone for opioid dependence: Section B: Confirm access to collaboration and supports in your practice setting: Employer support for prescribing methadone for opioid dependence: Y N Access to employer policies for prescribing methadone for opioid dependence: Y N Access to program/laboratory services for the regular testing of patients for drugs of abuse: Y N Access to an experienced methadone prescriber for consultation/mentoring Y N Registered with the Pharmacy Network and have access to the Pharmacy Network for purposes of reviewing a patient s medication profile Y N Initials 1

2 NP Application for Authority/Exemption to Prescribe Methadone for Opioid Dependence Part A (Initial application) Education and Training (attach certificates/documentation confirming completion): Centre for Addiction and Mental Health(CAMH) Opioid Dependence Treatment (ODT) Core Course: Y N College of Physicians and Surgeons of NL (CPSNL) Introduction to Safe Prescribing: Opioids, Benzodiazepines and Stimulants: Y N Clinical training (minimum of two days) with an experienced methadone provider/team: Y N Section C: Letters of Support (attach a letter of support from your current nursing manager/supervisor confirming their support for you to prescribe methadone for opioid dependence. Manager/Supervisor Name: Manager/Supervisor contact information: Section D: NPs employed outside a Regional Health Authority: Identify the name and contact information of a mentor (who may be different from your collaborating physician) and who has expertise in addictions management and/or substance use disorders and expertise in prescribing Methadone. Mentor Name Mentor Contact Information/Phone Number Attach the policies that guide your practice in relation to prescribing Methadone and care of patient receiving Methadone for opioid dependence: Policies attached Y N Initials 2

3 Section E: NP Application for Authority/Exemption to Prescribe Methadone for Opioid Dependence Part A (Initial application) Nurse Practitioner s Declarations I hereby apply for a section 56 exemption under the Controlled Drugs and Substances Act to prescribe methadone for opioid dependence and declare that the information I have provided in this application is true and correct. I declare that I am knowledgeable of the current version of the CPSNL s Methadone Maintenance Treatment Standards and Guidelines document. I declare that I am knowledgeable of the current version of the Newfoundland & Labrador Pharmacy Board s (NLPB) Standards for the Safe and Effective Provision of Methadone for the Treatment of Opioid Dependence. I declare that, when necessary, I will consult with more experienced prescribers of Methadone to enhance my knowledge and ensure patient safety as needed during induction or re-induction after missed doses. I understand that I am required to complete the CAMH Opioid Dependence Treatment Certificate Program or a course/education program deemed equivalent by ARNNL as part of continuing education in opioid dependence within three years of being granted Authority(exemption) to prescribe Methadone for opioid dependence. I declare that I have read and agree with each of the declaration statements listed above. I hereby give consent to the ARNNL to: (1) release information from my ARNNL registration/member file pertaining to my application to be granted authority to prescribe methadone for opioid dependence (exemption) to the Office of Controlled Substances, Health Canada, and (2) to complete any other action related to the request for a section 56 exemption under the Controlled Drugs and Substances Act. NP Signature If you have more than one practice setting where Methadone for Opioid Dependence is prescribed you must contact ARNNL for further direction. When ARNNL receives approval of the Exemption from Health Canada you will be notified by when authority to prescribe Methadone for opioid dependence had been granted. A link to the names of authorized prescribers will display to the ARNNL member search For Office Use Only: Part A Received: Part B Received: Part C Received: Part D Received: Health Canada Exemption Sent: Health Canada Exemption received: Approved: Signature: Initials 3

4 NP Prescriptive Authority: Methadone for Opioid Dependence Part B: Employer Statement Please complete Section A and forward this form to the Program Manager/Nurse Manager/Supervisor at place(s) of employment requesting completion. Section A: Nurse Practitioner Information Surname Given Name Telephone Number Address ARNNL NP Registration/Licensure # I hereby give consent for my employer to release the information as requested by ARNNL. Signature of Nurse Practitioner Section B: Statement of Current Employer The above-named Nurse Practitioner has applied to ARNNL to be granted the authority(exemption) to prescribe Methadone for Opioid Dependence in his/her NP practice. Please complete the following statement indicating the employer s support for this nurse practitioner to prescribe Methadone for Opioid Dependence. Please return the completed document directly to ARNNL at registration@arnnl.ca. Employer Name: Employer Address: Do you support this NP to prescribe Methadone for Opioid Dependence in their current practice setting: Y N Do you confirm that the employer has a policy(s) in place to guide a NP in their practice to prescribe Methadone for Opioid Dependence and care of clients receiving Methadone for Opioid Dependence: Y N Do you confirm that the above named Nurse Practitioner has access to a mentor who has expertise in prescribing Methadone for Opioid Dependence: Y N Signature Position/Title

5 NP Prescriptive Authority: Methadone for Opioid Dependence Part C: Confirmation of Clinical Training Please complete Section A and forward this form to the methadone provider/team who provided clinical training. Section A: Nurse Practitioner Information Surname Given Name Telephone Number Address ARNNL NP Registration/Licensure # I hereby give consent for my employer to release the information as requested by ARNNL. Signature of Nurse Practitioner Section B: Statement of Methadone Provider/Team who provided Clinical Training The above-named Nurse Practitioner has applied to ARNNL to be granted the authority(exemption) to prescribe Methadone for Opioid Dependence in his/her NP practice. In accordance with ARNNL policy an NP must complete a minimum of two days of clinical training with an experienced methadone provider/team prior to be granted prescriptive authority(exemption) for Methadone for Opioid Dependence. Please complete the following statement confirming this Nurse Practitioner s completion of clinical training. Please return the completed document directly to ARNNL at registration@arnnl.ca. On the above-named nurse practitioner completed two days of clinical training with, an experienced Methadone provider/team at. Name Location/Program Signature Position/Title

6 NP Prescriptive Authority: Methadone for Opioid Dependence Part D: Confirmation of Mentor FOR NURSE PRACTITIONERS (NPs) WHO ARE EMPLOYED OUTSIDE OF A REGIONAL HEALTH AUTHORITY IN NEWFOUNDLAND AND LABRADOR (INCLUDES SELF EMPLOYMENT) I, understand that it is a requirement of Council to be granted authority (exemption) to prescribe Methadone for Opioid Dependence that I have access to a mentor who has expertise in prescribing Methadone for Opioid Dependence. I, confirm that I have access to a mentor with expertise in prescribing Methadone for Opioid Dependence. The employer s name is: The Mentor s name is: Employer s address and contact information: Mentors address and contact information: I understand that I am required to immediately notify ARNNL should any of the information provided above change, with respect to access to a mentor. Nurse Practitioners Signature: Mentor s Signature: : : Mentor License #:

NP Application for Authority to Prescribe Methadone for Opioid Dependence Part A (Initial application)

NP Application for Authority to Prescribe Methadone for Opioid Dependence Part A (Initial application) NP Application for Authority to Prescribe Methadone for Opioid Dependence Part A (Initial application) Complete each section and initial the bottom of each page. Section A: Name ARNNL NP Licensure/Registration

More information

NP Application for Authority to Prescribe Buprenorphine-Naloxone (Suboxone) Part A

NP Application for Authority to Prescribe Buprenorphine-Naloxone (Suboxone) Part A NP Application for Authority to Prescribe Buprenorphine-Naloxone (Suboxone) Part A Complete each section and initial the bottom of each page. Section A: Name ARNNL NP Licensure/Registration # Phone Number

More information

Requirements for Nurse Practitioners to Prescribe Buprenorphine-Naloxone (Suboxone):

Requirements for Nurse Practitioners to Prescribe Buprenorphine-Naloxone (Suboxone): Nurse Practitioner Change in Scope of Practice: Education and Practice Requirements for Nurse Practitioners (NPs) to Prescribe Buprenorphine-Naloxone (Suboxone) and Methadone On October 20 th, 2017, ARNNL

More information

Destruction of Narcotics, Controlled Drugs and other Targeted Substances

Destruction of Narcotics, Controlled Drugs and other Targeted Substances Destruction of Narcotics, Controlled Drugs and other Targeted Substances Pharmacists may now proceed with destruction of narcotics and/or controlled substances without requesting and receiving authorization

More information

FULL REGISTRATION (365-DAY RULE EXEMPT) APPLICATION FOR PATHWAY 1

FULL REGISTRATION (365-DAY RULE EXEMPT) APPLICATION FOR PATHWAY 1 THE COLLEGE OF DENTAL HYGIENISTS OF BRITISH COLUMBIA Suite 600, 3795 Carey Road Telephone: (250) 383-4101 Victoria, British Columbia, V8Z 6T8 Facsimile: (250) 383-4144 www.cdhbc.com Email: cdhbc@cdhbc.com

More information

Review of Controlled Drugs and Substances Act

Review of Controlled Drugs and Substances Act Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A

More information

COAHOMA COUNTY SCHOOL DISTRICT Application for Interim Superintendent of Schools

COAHOMA COUNTY SCHOOL DISTRICT Application for Interim Superintendent of Schools COAHOMA COUNTY SCHOOL DISTRICT Application for Interim Superintendent of Schools (Please type or print your responses and fully respond to each item.) I. BASIC INFORMATION Name: (Last) (First) (Middle)

More information

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Minnesota Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT c t DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to September 22, 2014. It is intended

More information

Opioid Treatment Program Reimbursement Re-bundling Proposal

Opioid Treatment Program Reimbursement Re-bundling Proposal Opioid Treatment Program Reimbursement Re-bundling Proposal Maryland Department of Health and Mental Hygiene April 22, 2016 The Department reviewed close to 50 letters and emails submitted by stakeholders

More information

Vermont Hub and Spoke Model Treatment Need Questionnaire

Vermont Hub and Spoke Model Treatment Need Questionnaire Vermont Hub and Spoke Model Treatment Need Questionnaire Friday, June 30, 2017 John Brooklyn, MD Assistant Professor of Family Medicine and Psychiatry University of Vermont Burlington, Vermont Webinar

More information

Methadone/Buprenorphine 101

Methadone/Buprenorphine 101 Methadone/Buprenorphine 101 October 1, 2016 Joy Bhimji, BSP Manager, Drug Programs College of Physicians and Surgeons of British Columbia 2 http://www2.gov.bc.ca/assets/gov/health/about-bc-s-health-care-system/office-of-the-provincial-healthofficer/reports-publications/special-reports/bc-ost-system-measures-2013-2014.pdf

More information

OPIOID USE DISORDER CENTERS OF EXCELLENCE APPLICATION GENERAL INFORMATION

OPIOID USE DISORDER CENTERS OF EXCELLENCE APPLICATION GENERAL INFORMATION OPIOID USE DISORDER CENTERS OF EXCELLENCE APPLICATION GENERAL INFORMATION The Department of Human Services (DHS) is implementing 50 opioid use disorder (OUD) Health Homes or Centers of Excellence (COE)

More information

User Guide for Transition to the Drug Information System

User Guide for Transition to the Drug Information System User Guide for Transition to the Drug Information System Document Revision History Date Description Version Updated By August 12, 2013 New/revised content 1.0 Lori Emery Version 1.0 Page 2 of 13 Table

More information

Evidence-Based Clinical Practice Guideline. Treatment & Management of Ocular Disease

Evidence-Based Clinical Practice Guideline. Treatment & Management of Ocular Disease Evidence-Based Clinical Practice Guideline Treatment & Management of Ocular Disease Effective November 29, 2017 Treatment & Management Of Ocular Disease Clinical Practice Guideline The objective of this

More information

Ontario s Narcotics Strategy

Ontario s Narcotics Strategy Ontario s Narcotics Strategy Ontario Public Drug Programs Ministry of Health and Long-Term Care January 31, 2012 Ontario Harm Reduction Distribution Program Conference 2012 1 Background The Need for Action

More information

Medication Agreements Promoting awareness, dialogue and level-set expectations

Medication Agreements Promoting awareness, dialogue and level-set expectations Medication Agreements Promoting awareness, dialogue and level-set expectations A young man had his leg amputated following a work-related injury. His pain doctor, by all accounts, was trying to responsibly

More information

Prescribing and Dispensing Drugs

Prescribing and Dispensing Drugs STANDARDS & GUIDELINES Prescribing and Dispensing Drugs TABLE OF CONTENTS Standards and guidelines inform practitioners and the public of CDSBC s expectations for registrants. This document primarily contains

More information

WILLIAMS, WYCKOFF & OSTRANDER, PLLC Attorneys at Law

WILLIAMS, WYCKOFF & OSTRANDER, PLLC Attorneys at Law WILLIAMS, WYCKOFF & OSTRANDER, PLLC Attorneys at Law Wayne L. Williams Douglas P. Wyckoff Dane D. Ostrander 2958 Limited Lane N.W. P O Box 316 Olympia, WA 98507 Telephone (360) 528-4800 Telefax (360) 943-2430

More information

Nurse Practitioner Practice Guideline Treatment Agreements

Nurse Practitioner Practice Guideline Treatment Agreements Nurse Practitioner Practice Guideline Treatment Agreements In November 2012, the New Classes of Practitioners Regulations (NCPR) under Canada s Controlled Drug and Substances Act (CDSA) came into force,

More information

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid

More information

S 0332 S T A T E O F R H O D E I S L A N D

S 0332 S T A T E O F R H O D E I S L A N D LC00 01 -- S 0 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO HEALTH AND SAFETY - COMPREHENSIVE DISCHARGE PLANNING Introduced By: Senators Miller,

More information

SASKATCHEWAN METHADONE PROGRAM

SASKATCHEWAN METHADONE PROGRAM College of Physicians and Surgeons of Saskatchewan SASKATCHEWAN METHADONE PROGRAM Annual Report 2014 Date submitted: 11 September, 2015 P a g e 2 Table of Contents ANNUAL REPORT 2014... 3 About the Methadone

More information

Alberta WCB Policies & Information

Alberta WCB Policies & Information 1. What are the objectives of WCB regarding the authorization of prescribed opioid analgesics As part of an overall approach to effective, appropriate claims management, including the provision of and

More information

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid

More information

STATE OF FLORIDA DEPARTMENT OF HEALTH

STATE OF FLORIDA DEPARTMENT OF HEALTH DEPARTMENT OF HEALTH, STATE OF FLORIDA DEPARTMENT OF HEALTH PETITIONER, V. RYAN P. WATSON, R.N., CASE NO. 2017-20520 RESPONDENT. ADMINISTRATIVE COMPLAINT COMES NOW, Petitioner, Department of Health, by

More information

Opioids drive continued increase in drug overdose deaths

Opioids drive continued increase in drug overdose deaths CDC: Drug overdose deaths increase for 11th consecutive year Opioids drive continued increase in drug overdose deaths Atlanta, GA, USA (February 20, 2013) - Drug overdose deaths increased for the 11th

More information

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Ministry of Health and Long-Term Care. Presentation to the CPSO Methadone Prescribers Conference

Ministry of Health and Long-Term Care. Presentation to the CPSO Methadone Prescribers Conference Ministry of Health and Long-Term Care Presentation to the CPSO Methadone Prescribers Conference November 9, 2012 Overview Minister s Expert Working Group on Narcotic Addiction OxyNEO and OxyContin: Changes

More information

ATTUD APPLICATION FORM FOR WEBSITE LISTING (PHASE 1): TOBACCO TREATMENT SPECIALIST (TTS) TRAINING PROGRAM PROGRAM INFORMATION & OVERVIEW

ATTUD APPLICATION FORM FOR WEBSITE LISTING (PHASE 1): TOBACCO TREATMENT SPECIALIST (TTS) TRAINING PROGRAM PROGRAM INFORMATION & OVERVIEW ATTUD APPLICATION FORM FOR WEBSITE LISTING (PHASE 1): TOBACCO TREATMENT SPECIALIST (TTS) TRAINING PROGRAM APPLICATION NUMBER: TTS 2010_2_0011 PROGRAM INFORMATION & OVERVIEW Date of this Application 2/01/10

More information

2016 Dr. Douglas H. Kay CPE Symposium

2016 Dr. Douglas H. Kay CPE Symposium GREGORY CAMERON, R.Ph ASSISTANT PROFESSOR OF PHARMACY PRACTICE FIELD COORDINATOR COMMUNITY SITES HUSSON UNIVERSITY SCHOOL OF PHARMACY November 5, 2016 Please Silence All Electronic Equipment OBJECTIVES

More information

S 2356 SUBSTITUTE A AS AMENDED ======== LC004564/SUB A/3 ======== S T A T E O F R H O D E I S L A N D

S 2356 SUBSTITUTE A AS AMENDED ======== LC004564/SUB A/3 ======== S T A T E O F R H O D E I S L A N D 0 -- S SUBSTITUTE A AS AMENDED LC00/SUB A/ S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 0 A N A C T RELATING TO HEALTH AND SAFETY -- INSURANCE--MENTAL ILLNESS AND SUBSTANCE

More information

INITIAL PRACTICE PERIOD FORMS

INITIAL PRACTICE PERIOD FORMS INITIAL PRACTICE PERIOD FORMS 5060-3080 Yonge Street, Box 71 Toronto, Ontario M4N 3N1 416-975-5347 1-800-993-9459 www.caslpo.com Revised: May 2017 TABLE OF CONTENTS 1 MENTORSHIP GUIDANCE CONTRACT 3 2 1

More information

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Therapeutic Use Exemption (TUE) Checklist and Application

Therapeutic Use Exemption (TUE) Checklist and Application Therapeutic Use Exemption (TUE) Checklist and Application Attention Deficit Disorder (ADD) and Attention Deficit and Hyperactivity Disorder (ADHD) Step 1: Read all about Therapeutic Use Exemptions (TUE)

More information

Addressing the Harms of Prescription Drugs in Canada

Addressing the Harms of Prescription Drugs in Canada www.ccsa.ca www.cclt.ca Addressing the Harms of Prescription Drugs in Canada Innovations & Policy Solutions for Addressing Prescription Drug Abuse April 30, 2014 Rita Notarandrea, Canadian Centre on Substance

More information

Interprofessional Primary Care Medical Directive for Smoking Cessation

Interprofessional Primary Care Medical Directive for Smoking Cessation Insert Logo or Org Name Here Interprofessional Primary Care Medical Directive for Smoking Cessation Adapted from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 14,

More information

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts. PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to July 1, 2012. It is intended for information and reference purposes only. This

More information

Prepublication Requirements

Prepublication Requirements Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals

More information

Be it enacted by the People of the State of Illinois,

Be it enacted by the People of the State of Illinois, AN ACT concerning education. Be it enacted by the People of the State of Illinois, represented in the General Assembly: Section 5. The School Code is amended by changing Section 22-30 as follows: (105

More information

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Rhode Island Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

MODIFICATION OF APPLICATION TO BECOME A LICENSED PRODUCER UNDER THE ACCESS TO CANNABIS FOR MEDICAL PURPOSES REGULATIONS

MODIFICATION OF APPLICATION TO BECOME A LICENSED PRODUCER UNDER THE ACCESS TO CANNABIS FOR MEDICAL PURPOSES REGULATIONS MODIFICATION OF APPLICATION TO BECOME A LICENSED PRODUCER UNDER THE ACCESS TO CANNABIS FOR MEDICAL PURPOSES REGULATIONS (ACMPR) (Disponible en français) This form should be used if you already submitted

More information

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015.

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile New Mexico Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

RE: PROPOSED AMENDMENTS TO REGULATIONS TO THE CONTROLLED DRUGS AND SUBSTANCES ACT

RE: PROPOSED AMENDMENTS TO REGULATIONS TO THE CONTROLLED DRUGS AND SUBSTANCES ACT November 8, 2017 Ms. Michelle Boudreau Director General Controlled Substances Directorate Office of Legislative and Regulatory Affairs Health Canada 150 Tunney s Pasture Driveway, Main Stats Building Address

More information

Therapeutic Use Exemption (TUE) Policy

Therapeutic Use Exemption (TUE) Policy Therapeutic Use Exemption (TUE) Policy Following an amendment to the Irish Anti-Doping Rules by the Council on 6th April 2010, the Irish Sports Council has established a Therapeutic Use Exemption (TUE)

More information

COLLEGE OF PHYSICIANS AND SURGEONS OF NOVA SCOTIA DECISION OF INVESTIGATION COMMITTEE A. Mr. Kevin Lynch, Manager, PMP XXXXXXXXXXX

COLLEGE OF PHYSICIANS AND SURGEONS OF NOVA SCOTIA DECISION OF INVESTIGATION COMMITTEE A. Mr. Kevin Lynch, Manager, PMP XXXXXXXXXXX COLLEGE OF PHYSICIANS AND SURGEONS OF NOVA SCOTIA IN THE MATTER OF: DECISION OF INVESTIGATION COMMITTEE A COMPLAINANT: PHYSICIAN: Mr. Kevin Lynch, Manager, PMP XXXXXXXXXXX Dr. Philip Davis PROCESS: This

More information

Recommended Component: Assure Immediate Access to Medications as Prescribed

Recommended Component: Assure Immediate Access to Medications as Prescribed Recommended Component: Assure Immediate Access to Medications as Prescribed Students must have immediate access to all medications as approved by healthcare providers and parents, regardless of the availability

More information

Established in Locally Owned & Independently Operating. Physicians, Nurse Practitioners, Physician Assistants

Established in Locally Owned & Independently Operating. Physicians, Nurse Practitioners, Physician Assistants Established in 1987 Locally Owned & Independently Operating Physicians, Nurse Practitioners, Physician Assistants Please Fax all Compounding RX s to: Fax: 630.530.0295 For assistance call: 855.770.6313

More information

Opioid Abuse and Prescribing. Dr. Mitchell Mutter Director of Special Projects

Opioid Abuse and Prescribing. Dr. Mitchell Mutter Director of Special Projects Opioid Abuse and Prescribing Dr. Mitchell Mutter Director of Special Projects Auburn University February 22, 2019 Disclosure Statement of Financial Interest I, Mitchell Mutter, DO NOT have a financial

More information

8/16/2018. California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives. Agenda. No Wrong Door

8/16/2018. California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives. Agenda. No Wrong Door California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives Gloria Miele, PhD, Learning Collaborative Coordinator, Hub and Spoke MAT Expansion Project Richard Rawson, PhD, Professor

More information

ORDER OF THE LIEUTENANT GOVERNOR IN COUNCIL

ORDER OF THE LIEUTENANT GOVERNOR IN COUNCIL PROVINCE OF BRITISH COLUMBIA ORDER OF THE LIEUTENANT GOVERNOR IN COUNCIL Order in Council No. 542, Approved and Ordered October 5, 2018 Executive Council Chambers, Victoria On the recommendation of the

More information

I am pleased to highlight for this Honourable House and the public. that today the Government will be laying amendments to the

I am pleased to highlight for this Honourable House and the public. that today the Government will be laying amendments to the MINISTERIAL STATEMENT TO THE HOUSE OF ASSEMBLY BY THE HONOURABLE KIM N. WILSON, JP, MP MINISTER OF HEALTH UPDATES AND MODERNIZATION OF DRUG SCHEDULES 24 November 2017 Mr Speaker and Honourable Members,

More information

Prescription Monitoring Program (PMP)

Prescription Monitoring Program (PMP) 06/15/2018 FACT SHEET Implementation of Enacted Prescribing Limits and Requirements and Relevant Opioid Prescribing Laws and Rules Background: The 2016 law (Chapter 488) makes five major changes to opioid

More information

Ophthalmologist/Optometrist/Low Vision Clinic Report. 1.1 Title: (Mr/Mrs/Miss, etc) Surname: Full Names:. 1.4 Physical Address:.

Ophthalmologist/Optometrist/Low Vision Clinic Report. 1.1 Title: (Mr/Mrs/Miss, etc) Surname: Full Names:. 1.4 Physical Address:. OPTIMA COLLEGE COMPUTER SKILLS PROGRAMME APPLICATION FORM PLEASE NOTE: Incomplete applications will not be considered. Please ensure that the following are attached: Medical Report Ophthalmologist/Optometrist/Low

More information

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Virginia. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

WA PMP Access by Public Payers. PDMP North Regional Meeting St. Louis, MO April 23-24

WA PMP Access by Public Payers. PDMP North Regional Meeting St. Louis, MO April 23-24 WA PMP Access by Public Payers PDMP North Regional Meeting St. Louis, MO April 23-24 Public Insurer Access PDMP Statute: Allows PDMP data to be provided to Medicaid and Workers Compensation Primary Goal:

More information

Idaho DUR Board Meeting Minutes

Idaho DUR Board Meeting Minutes Idaho DUR Board Meeting Minutes Date: July 20, 2017 Time: 9am-12:30pm Location: Holiday Inn Boise Airport 2970 West Elder Street, Boise, Idaho, 83705 Moderator: David Agler, M.D. Committee Member Present:

More information

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being

More information

The Professional Relationships Associated with the Practice of Dental Therapy Practice Standard

The Professional Relationships Associated with the Practice of Dental Therapy Practice Standard The Professional Relationships Associated with the Practice of Dental Therapy Practice Standard December 2006 I:\Communications\C7 - Website\Practice standards rebranded Aug15\Dental therapy working relationship

More information

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription

More information

State, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP

State, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP State, District, or Territory Alabama Arizona Arkansas Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate, the applicant shall have a current

More information

Application Instructions for:

Application Instructions for: Regular Mailing Address Courier Delivery Address Application Instructions for: MASSAGE THERAPIST LICENSURE FOR EXISTING PRACTITIONERS USE THIS APPLICATION ONLY IF YOU WERE AN EXITISTING PRACTITIONER ON

More information

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable Alaska Requires adoption of regulations that provide that a practitioner query the PDMP prior to dispensing, prescribing, or administering a Sch. II or III controlled substance; query is not required for

More information

Recent trends in medical cannabis use in Canada

Recent trends in medical cannabis use in Canada Recent trends in medical cannabis use in Canada Paul Grootendorst Faculty of Pharmacy, University of Toronto Department of Economics, McMaster University Cannabis therapeutic effects Cannabis has been

More information

Mary Barkey Clinical Excellence Award NOMINATION FORM

Mary Barkey Clinical Excellence Award NOMINATION FORM NOMINATION FORM Please type your responses into this form, save with the award nominee s first initial and last name (example: EPlank-Nomination), and submit it via email to awards@childlife.org. Please

More information

Minister s Opioid Emergency Response Commission Recommendations to the Minister Updated July 5, 2018

Minister s Opioid Emergency Response Commission Recommendations to the Minister Updated July 5, 2018 The Minister s Opioid Emergency Response Commission was established May 31, 2017 to support the Government of Alberta s urgent response to the opioid crisis. As part of its mandate, the Commission is responsible

More information

Cannabis for Medical Purposes

Cannabis for Medical Purposes College of Physicians and Surgeons of British Columbia Cannabis for Medical Purposes Preamble This document is a standard of the Board of the College of Physicians and Surgeons of British Columbia. College

More information

Patient Agreement for the use of Opioid Medications

Patient Agreement for the use of Opioid Medications today s date Patient Name date of birth Patient Agreement for the use of Opioid Medications The purpose of this agreement is to give you information about the medications that may be part of your treatment

More information

Section I. Short-acting opioid Prior Authorization Criteria

Section I. Short-acting opioid Prior Authorization Criteria Request for Prior Authorization for Opioid analgesics Website Form www.highmarkhealthoptions.com Submit request via: Fax - 1-855-476-4158 Requests for opioid analgesics may be subject to prior authorization

More information

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update Bureau of Professional Licensing MAPS Updates & Opportunities April 28, 2018 Presented by Andrew Hudson, Manager Haley Winans, Analyst Drug Monitoring Section Bureau of Professional Licensing BPL-MAPS@Michigan.gov

More information

4/12/2018. Disclosure Statement of Financial Interest

4/12/2018. Disclosure Statement of Financial Interest Consultant/Over Prescribing Team 4/12/2018 Tennessee Chronic Pain Guidelines and Controlled Substance Efforts Symposia Linda Johnson, DNP APRN Consultant/Over Prescribing Team Disclosure Statement of Financial

More information

Reference Forms. Rev. Jan Vocational Rehabilitation Association of Canada

Reference Forms. Rev. Jan Vocational Rehabilitation Association of Canada Rev. Jan 2016 INFORMATION VRA Canada is a national association representing members across Canada who provide a continuum of rehabilitation services. Members are from a diversity of disciplines and are

More information

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3) NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 218 () Substance Abuse Epidemiology Section Prescription Drug Overdose Prevention Program Injury and Behavioral Epidemiology Bureau

More information

Dear Parent or Guardian,

Dear Parent or Guardian, Dear Parent or Guardian, This summer may be a period of transition for you and your child. For a lot of our students it may even be the first time they are taking the lead in their personal care, including

More information

Mary Barkey Clinical Excellence Award

Mary Barkey Clinical Excellence Award NOMINATION ENDORSEMENT FORM (Primary Endorser) Please type your responses into this form, save with the award nominee s first initial and last name (example: EPlank-EndorsementForm1) and submit it via

More information

Newfoundland and Labrador Pharmacy Board Standards of Practice

Newfoundland and Labrador Pharmacy Board Standards of Practice Newfoundland and Labrador Pharmacy Board Standards of Practice Standards for the Safe and Effective Administration of Drug Therapy by Inhalation or Injection June 2015 Table of Contents 1) Introduction...

More information

ADVANCED LEARNING SCHOLARSHIP. Including the. JOHN and BETTY ROSE SCHOLARSHIP APPLICATION. All applications to be posted to:

ADVANCED LEARNING SCHOLARSHIP. Including the. JOHN and BETTY ROSE SCHOLARSHIP APPLICATION. All applications to be posted to: ADVANCED LEARNING SCHOLARSHIP Including the JOHN and BETTY ROSE SCHOLARSHIP APPLICATION All applications to be posted to: The Secretary New Zealand Federation for Deaf Children Inc Johnsonville Wellington

More information

Dreamers Child Care Enrollment Application

Dreamers Child Care Enrollment Application Dreamers Child Care Enrollment Application Child s Full Name Gender Birth Date Address Home Phone Chronic Physical Problems / Pertinent Developmental Information / Special Accommodations Needed Previous

More information

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES TITLE 16 CHAPTER 10 PART 14 OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES 16.10.14.1 ISSUING AGENCY: New

More information

Understanding the New Access to Cannabis for Medical Purposes Regulations

Understanding the New Access to Cannabis for Medical Purposes Regulations Understanding the New Access to Cannabis for Medical Purposes Regulations Health Canada August 2016 Table of Contents 1. Introduction 2. Health Canada's role 3. What it means for health care practitioners

More information

RADIOLOGIST ASSISTANT MASTER S PROGRAM APPLICANT PROCEDURES & CHECK LIST

RADIOLOGIST ASSISTANT MASTER S PROGRAM APPLICANT PROCEDURES & CHECK LIST RADIOLOGIST ASSISTANT MASTER S PROGRAM APPLICANT PROCEDURES & CHECK LIST APPLICATION PROCEDURES Please read the following procedures carefully. All applicants must submit the items listed in the checklist

More information

- and. IN THE MATTER OF: The Medical Act, R.S.N.S , c and SETTLEMENT AGREEMENT

- and. IN THE MATTER OF: The Medical Act, R.S.N.S , c and SETTLEMENT AGREEMENT PROVINCE OF NOVA SCOTIA ) COUNTY OF HALIFAX ) IN THE MATTER OF: The Canada Evidence Act - and IN THE MATTER OF: The Medical Act, R.S.N.S. 1995-96, c.10 - and IN THE MATTER OF: Dr. David Russell SETTLEMENT

More information

Dear Colleague GENERAL OPHTHALMIC SERVICES OPTOMETRY INDEPENDENT PRESCRIBING. Summary

Dear Colleague GENERAL OPHTHALMIC SERVICES OPTOMETRY INDEPENDENT PRESCRIBING. Summary NHS: PCA(O)(2013)4 Health and Social Care Integration Directorate Primary Care Division Dear Colleague GENERAL OPHTHALMIC SERVICES OPTOMETRY INDEPENDENT PRESCRIBING Summary 1. This letter advises NHS Boards

More information

ANNEXURE A SUPPLIER DECLARATION FORM P a g e

ANNEXURE A SUPPLIER DECLARATION FORM P a g e ANNEXURE A SUPPLIER DECLARATION FORM - 1 - P a g e Health Professions Council of South Africa This form must be completed and submitted with TENDER: Health Professions Council of South Africa P O Box 205

More information

PART 1306 PRESCRIPTIONS. 21 CFR Ch. II ( Edition)

PART 1306 PRESCRIPTIONS. 21 CFR Ch. II ( Edition) 1305.16 1305.16 Special procedure for filling certain order forms. (a) The purchaser of carfentanil etorphine hydrochloride or diprenorphine shall submit copy 1 and 2 of the order form to the supplier

More information

CHAPTER NINE INSULIN AND GLUCAGON ADMINISTRATION

CHAPTER NINE INSULIN AND GLUCAGON ADMINISTRATION CHAPTER NINE INSULIN AND GLUCAGON ADMINISTRATION SECTION I PURPOSE AND AUTHORITY A. REGULATORY AUTHORITY 1. These rules shall be known as the Arkansas Department of Education and Arkansas State Board of

More information

ASPMN Conference Baltimore, Maryland

ASPMN Conference Baltimore, Maryland ASPMN Conference Baltimore, Maryland Prescribing Controlled Substances Managing Risk and Optimizing Outcomes September 13, 2012 Tracey Fremd, NP Tracey Fremd Consulting, Inc. Most Common Uses for Controlled

More information

Alcohol and Other Drug Service Definitions

Alcohol and Other Drug Service Definitions Table of Contents OAC 3793:2-1-08 Treatment services (E) Consultation... 2 (F) Referral and information service... 2 (G) Intervention service... 2 (H) Hotline service... 2 (I) Training service (non-prevention)...

More information

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established? Where Can I Find A Copy of the PDMP Law? Alabama Uniform Controlled Substances Act Code of Alabama 1975 20-2- (Article 10) -210 through 220 and Rules 420-7-2-.11 through.13 1 Why Was the Law Established?

More information

RPL Form Certificate IV in Fitness SIS40215

RPL Form Certificate IV in Fitness SIS40215 Please read the information below and complete all sections of this form. RPL Form Certificate IV in Fitness SIS40215 Recognition of Prior Learning (RPL) ACFB provides a simple process in gaining Recognition

More information

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine Financial Disclosure I have no relevant financial relationships

More information

MEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent

MEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent MEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent Pain may be effectively managed through the use of controlled substance medications (referred to below as opioids

More information

Dear Applicant for Sober Living Environment Registration,

Dear Applicant for Sober Living Environment Registration, Dear Applicant for Sober Living Environment Registration, Thank you for your interest in Sober Living Registration. The California Consortium of Addiction Programs and Professionals, (CCAPP) endorses the

More information

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 2017 (2017Q4)

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 2017 (2017Q4) NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 217 () Substance Abuse Epidemiology Section Prescription Drug Overdose Prevention Program Injury and Behavioral Epidemiology Bureau

More information

New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers

New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers CENTERS FOR MEDICARE & MEDICAID SERVICES New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers Background CMS understands the magnitude of the nation s opioid epidemic and

More information

Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors

Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors This educational call is sponsored by the Enterprise Risk Management Task Force. Thursday, April 11, 2013 11:00 am 12:00

More information

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

On December 27, 2017, the Lieutenant Governor signed into law several new requirements OPIOID Alert MICHIGAN OSTEOPATHIC ASSOCIATION JANUARY 2018 On December 27, 2017, the Lieutenant Governor signed into law several new requirements aimed at combating the opioid epidemic. On the following

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: LA.PPA.12 Effective Date: 02/11 Last Review Date: 01/18 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end of this policy for

More information

January 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9

January 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9 January 19, 2018 Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9 By email: cannabis@canada.ca RE: Proposed Approach to the Regulation of Cannabis

More information